CTS Corporation (CTS) Cash Flow Statement

The OCF/NI ratio has been consistently above 1.0, peaking at 2.45x in 2026Q3 — a pattern that typically indicates high-quality earnings with limited aggressive revenue recognition, though the magnitude of the 2026Q3 gap (OCF of $43.5M vs NI of $17.8M) warrants scrutiny given the anomalous revenue run-rate flagged in recent context. A structural portion of the conversion premium comes from D&A add-backs of ~$8.7M per quarter, which mechanically inflates OCF relative to NI; stripping this out, the recurring conversion closer to 1.2–1.5x is still robust for a hardware manufacturer. The divergence between the prior income statement's concern about rising SBC (up 175% YoY) and this cash strength is partially reconciled because SBC is added back as a non-cash expense in OCF — meaning the 2.45x ratio in 2026Q3 flatters true economic conversion by $3.3M, or roughly 8% of that quarter's OCF.

The FCF margin trajectory shows a clear upward shift: the four quarters through 2024Q4 averaged roughly 14.5%, while the four most recent quarters average approximately 18.8%, with the latest quarter reaching 27.5%. However, this improvement is not linear — 2026Q1's FCF margin of 8.8% demonstrates how dramatically WC swings can distort quarterly optics, suggesting investors should anchor on TTM figures rather than single quarters. Compared to reported net income, cumulative FCF over 10 quarters was approximately $235M versus cumulative NI of $155.8M, implying the business converts approximately $1.50 of free cash per dollar of accounting profit — a profile consistent with low capital intensity and favorable working capital dynamics.

The sustained gap between depreciation and capital expenditure — roughly 2.3x in the latest quarter — suggests CTS is running a capital-light model where its specialized ceramic manufacturing assets are depreciating faster than they are being replaced or expanded. For a company executing a pivot toward medical and aerospace piezoelectric components, this pattern raises the question of whether capacity to support design-win conversion is being adequately funded, or whether the FCF profile is temporarily inflated by deferred maintenance. The 1.6% CapEx/Rev in 2026Q3 versus a 10-quarter average of ~3.1% indicates a step-down that, if sustained, could constrain the operational leverage thesis built on gross margin expansion — capacity utilization rates cited as a key driver cannot improve without corresponding asset investment.

The seasonal pattern is visible: Q1 working capital changes are consistently negative (-$11.7M in 2026Q1, -$7.7M in 2025Q1, -$2.9M in 2024Q2), reflecting inventory build ahead of production ramp and the timing of raw material procurement for silver and palladium inputs. The positive swing in 2026Q3 (+$8.9M) coincides with the revenue run-rate anomaly flagged in recent context ($564.0M actual vs $542.2M TTM), and investors should consider whether receivables are truly being collected or whether the reported revenue represents channel loading — the working capital data alone does not resolve this but the volatility pattern warrants monitoring. Cumulative working capital changes over 10 quarters net to approximately +$8.6M, indicating the multi-year cycle is roughly neutral to mildly accretive to cash, which is a stable pattern for a manufacturer of this profile.

The buyback program shows a deliberate pace-setting approach: $40.6M in TTM net buybacks, with 2025Q3 showing an anomalous +$23.0M inflow (potential buyback cancellation or share issuance) that contrasts with the steady -$6.5M to -$16.6M outflows in adjacent quarters. The near-absence of M&A activity since late 2024 — over six quarters — represents a meaningful pause relative to the prior pattern of bolt-on acquisitions in piezoelectric niches, and with a fortress balance sheet and minimal debt, CTS appears to have substantial dry powder should a strategic target emerge. However, the combination of low capex (44% of D&A) and minimal M&A means the 51% shareholder return ratio is being funded less by reinvestment in growth than by what may be under-deployment of operating cash flow — a pattern that could become a capital allocation concern if organic growth momentum decelerates.